Ultimately, the aim of a cancer vaccine is to strongly activate the CD8+ T-cell pathway, mediated by CD4+ T cells, thus overcoming self-tolerance and immune suppression, leading to the elimination of cancer cells. The gene discussed is CD8A; the disease is cancer.